Cellular replacement therapy for arrhythmia treatment: early clinical experience
- PMID: 18379864
- DOI: 10.1007/s10840-008-9244-z
Cellular replacement therapy for arrhythmia treatment: early clinical experience
Abstract
Clinical and experimental studies have demonstrated the proarrhythmic potential of skeletal myoblast transplantation for repair of infarcted myocardium. The evidence on proarrhythmia following bone marrow-derived stem cells, and particular msenchymal stem cells, transplantation is inconclusive. There are experimental and preliminary clinical data supporting the possibility that mesenchymal stem cell transplantation might exert an anti-arrhythmic action by intervening with myocardial scar remodeling. However, clinical experience is limited.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
